Cladribine and Ascites - a phase IV clinical study of FDA data

Summary:

Ascites is reported as a side effect among people who take Cladribine (cladribine), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Cyclosporine, and have Follicle centre lymphoma, follicular grade i, ii, iii stage iv.

The phase IV clinical study analyzes which people have Ascites when taking Cladribine. It is created by eHealthMe based on reports of 2,533 people who have side effects when taking Cladribine from the FDA, and is updated regularly.

What is Cladribine?

Cladribine has active ingredients of cladribine. eHealthMe is studying from 2,540 Cladribine users. Check the latest studies of Cladribine.

What is Ascites?

Ascites (accumulation of fluid in the abdominal cavity) is found to be associated with 1,528 drugs and 2,026 conditions by eHealthMe. Check the latest studies of Ascites.

On Jul, 13, 2026

2,533 people reported to have side effects when taking Cladribine.
Among them, 12 people (0.47%) have Ascites.

Among these 12 people:

How long have people been on Cladribine when they have Ascites? *

What is the gender of people who have Ascites when taking Cladribine? *

female: 41.67 %
male: 58.33 %

What is the age of people who have Ascites when taking Cladribine? *

What are other drugs people take besides Cladribine? *

What are other side effects people have besides Ascites? *

Pleural Effusion (water on the lungs): 6 people, 50.00%
Fever: 4 people, 33.33%
Multi-Organ Failure (multisystem organ failure): 4 people, 33.33%
Aspergillosis (an infection caused by a fungus called aspergillus): 3 people, 25.00%
Venoocclusive Liver Disease (small veins in the liver are obstructed): 3 people, 25.00%
Hepatic Failure (liver failure): 3 people, 25.00%
Hyperbilirubinaemia (excess of bilirubin in the blood): 3 people, 25.00%
Thrombocytopenia (decrease of platelets in blood): 3 people, 25.00%
Drug Ineffective: 3 people, 25.00%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 3 people, 25.00%

What are the existing conditions these people have? *

Hairy Cell Leukaemia (a type of blood cancer): 2 people, 16.67%
Follicle Centre Lymphoma, Follicular Grade I, Ii, Iii Stage Iv: 2 people, 16.67%
Xanthogranuloma (self-limiting tumour with self healing): 1 person, 8.33%
Osteopenia (a condition where bone mineral density is lower than normal): 1 person, 8.33%
Langerhans' Cell Histiocytosis: 1 person, 8.33%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Cladribine and have Ascites?

- Check whether Ascites is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cladribine:

Cladribine (2,540 reports)

Ascites treatments and more:

Ascites (42,930 reports)

Browse all side effects of Cladribine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ascites:

Ascites (1,528 drugs)

Browse all the conditions that are associated with Ascites:

Ascites (2,026 conditions)

Related publications that referenced our studies

Rajsekhar P, Reddy MM, Vaddera S, Rajini G, Tikeli V, "A Rare Case of Vitamin B12 Deficiency with Ascites", Journal of clinical and diagnostic research: JCDR, 2014 Jan .
Rajsekhar P, Reddy MM, Vaddera S, Rajini G, Tikeli V, "A Rare Case of Vitamin B12 Deficiency with Ascites", Journal of clinical and diagnostic research: JCDR, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on cladribine (the active ingredients of Cladribine) and Cladribine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.